BioPulse Posted - 1 day ago

@BioPulse Reasons I like $TVTX: PDUFA September 5th(Priority Review)👀 Trading Close to Cash 👀 Analyst Consensus > $18👀 Insider Activity ✅ 👀 5:1 Put:Call Ratio(September) 👀 Institutional Ownership 78%👀 35% Qtr Revenue Growth 👀 Cash Through 2028(!)👀 Needs Volume but one of my favorite catalyst trades this year ..

fda_tracker Posted - 1 week ago

$TVTX New PDUFA Date 2024-09-05 Travere Therapeutics, Inc. Link:https://www.globenewswire.com/news-release/2024/05/06/2876124/0/en/Travere-Therapeutics-Reports-First-Quarter-2024-Financial-Results.html Calendar:http://www.fdatracker.com/fda-calendar/

DonCorleone77 Posted - 1 week ago

$TVTX Travere Therapeutics reports Q1 EPS (1.51) , consensus (99c) Reports Q1 revenue $40M, consensus $42.85M."We are off to an excellent start to 2024. We are reporting new highs in both demand and revenue for FILSPARI in IgAN during the first quarter, with continuing strong trends into the second quarter. Additionally, the FDA recently granted Priority Review to our sNDA seeking the conversion of accelerated approval of FILSPARI to full approval for IgAN in the U.S., and FILSPARI recently received conditional marketing authorization for IgAN in Europe. Our strong performance and achievement of these key regulatory milestones furthers our confidence in being able to deliver significant growth in 2024 and beyond," said Eric Dube, Ph.D., president and chief executive officer of Travere Therapeutics. "Additionally, we remain on track with the other priorities to expand our growth, including dosing the first patients with HCU in our pivotal program designed to deliver pegtibatinase as the only disease modifying therapy for HCU. We also continue to review our data from the DUPLEX Study and engage with the nephrology community to facilitate our planned engagement with FDA on potential regulatory pathways for sparsentan in FSGS."

epsguid Posted - 1 week ago

$TVTX reported a loss of $1.76, consensus was ($0.98) via @eWhispers #epsmiss http://eps.sh/d/tvtx

Stock_Titan Posted - 1 week ago

$TVTX Travere Therapeutics Reports First Quarter 2024 Financial Results https://www.stocktitan.net/news/TVTX/travere-therapeutics-reports-first-quarter-2024-financial-w09iq4sfe1h2.html

Rumrunner5 Posted - 1 week ago

$TVTX well this is a quiet page.

Stock_Titan Posted - 04/29/24

$TVTX Travere Therapeutics to Report First Quarter 2024 Financial Results https://www.stocktitan.net/news/TVTX/travere-therapeutics-to-report-first-quarter-2024-financial-fraw3xjqog3d.html

MakingDreamsReality Posted - 04/24/24

PM mOOvers 👀 $TPET -Company Commences Oil Sales from California Assets $RILY - B. Riley soars after independent probe aligns with internal review findings $TVTX -CSL Vifor And Travere Therapeutics Granted European Commission Conditional Marketing Authorization For FILSPARI (Sparsentan) For The Treatment Of IgA Nephropathy $IMMP -Immutep Announced Tuesday, Data From Efti In Combination With Keytruda In First Line Head And Neck Squamous Cell Carcinoma Patients Who Do Not Express PD-L1 Shows A Preliminary 26.9% Response Rate, The Primary Endpoint Of The Study $SES -SES AI, Hyundai Motor and Kia Agree to Enter the Next Phase of Their Joint Development Contract

OpenOutcrier Posted - 04/24/24

$TVTX (+5.6% pre) Travere stock gains on EU nod for Filspari - SA https://seekingalpha.com/news/4093080-travere-stock-gains-eu-nod-filspari

boibs Posted - 04/19/24

$TVTX they posted poems and animals as opposed to presentation results and updates.

boibs Posted - 04/19/24

$TVTX

TradeHawk Posted - 04/19/24

$TVTX Travere Therapeutics and CSL Vifor get European Commission approval of Sparsentan for the treatment of IgA nephropathy. https://ec.europa.eu/transparency/documents-register/detail?ref=C(2024)2719&lang=en

squueeze Posted - 1 month ago

$CALT $TVTX

squueeze Posted - 1 month ago

$TVTX is poop. Look into $CALT instead

insiderbuyingselling Posted - 1 month ago

$TVTX new insider selling: 54 shares. http://insiderbuyingselling.com/?t=TVTX

boibs Posted - 1 month ago

$TVTX

boibs Posted - 1 month ago

$TVTX 76mm shares. 68mm institutional owned. 13mm shorted. How will shorts get out of this on good news. Imagine what a loaded.optionS chain would do (bobby 2)

Stock_Titan Posted - 1 month ago

$TVTX Travere Therapeutics to Present Abstracts at the Society for Inherited Metabolic Disorders and Genetic Metabolic Dieticians International https://www.stocktitan.net/news/TVTX/travere-therapeutics-to-present-abstracts-at-the-society-for-5aevzgglezq5.html

Sootwits Posted - 1 month ago

$TVTX will move before Apr 15th?

Stock_Titan Posted - 1 month ago

$TVTX Travere Therapeutics to Present Abstracts on FILSPARI® (sparsentan) in IgA Nephropathy at World Congress of Nephrology and the American Nephrology Nurses Association https://www.stocktitan.net/news/TVTX/travere-therapeutics-to-present-abstracts-on-filspari-r-sparsentan-o7u3wfkkxayr.html

Bigeyes2 Posted - 03/21/24

$TVTX

Fadoman Posted - 03/19/24

$TVTX good for an intraday trade... After taking profits I will go short before close or in the AHs

JackDarwin Posted - 2 months ago

$TVTX Bullish engulfing At Downtrend Momentum With Jump In Volume.

Stock_Titan Posted - 2 months ago

$TVTX Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://www.stocktitan.net/news/TVTX/travere-therapeutics-reports-inducement-grants-under-nasdaq-listing-240zk85ebwqr.html

Stock_Titan Posted - 2 months ago

$TVTX Travere Therapeutics Submits Supplemental New Drug Application to the U.S. Food and Drug Administration Seeking Full Approval of FILSPARI® (sparsentan) for the Treatment of IgA Nephropathy (IgAN) https://www.stocktitan.net/news/TVTX/travere-therapeutics-submits-supplemental-new-drug-application-to-zzu92rzqy83h.html

Stock_Titan Posted - 02/26/24

$TVTX Travere Therapeutics to Present at Upcoming Investor Conferences https://www.stocktitan.net/news/TVTX/travere-therapeutics-to-present-at-upcoming-investor-1cq1scq1wk8f.html

TickerDD_com Posted - 02/26/24

From 2/14/2024, looking back across 22 Month-Ends for TVTX, Percentage Change of Average Monthly Price had Equal (50%) while Percentage Change of Average Monthly Volume had All Positives (100%) $TVTX #TVTX #TVTXStock #TickerDD #TVTXPrice https://www.youtube.com/watch?v=X4pzIbRn9eg

OpenOutcrier Posted - 02/23/24

$TVTX (+5.6% pre) Travere Therapeutics (TVTX) and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatment of IgA Nephropathy - SI https://ooc.bz/l/25843

MMCT Posted - 02/23/24

$TVTX 🤔🤔🤔

TU6637 Posted - 02/23/24

$TVTX hmmm 🤔 This could be good https://www.stocktitan.net/news/TVTX/csl-vifor-and-travere-therapeutics-announce-sparsentan-receives-bf43sip7h99x.html